K
Selected References
- PDF / 196,409 Bytes
- 7 Pages / 595.28 x 790.87 pts Page_size
- 115 Downloads / 189 Views
L.K. Golightly et al. (eds.), Renal Pharmacotherapy, DOI 10.1007/978-1-4614-5800-5_10, © Springer Science+Business Media New York 2013
371
Dosage Adjustment of Medications Eliminated by the Kidneys
Kanamycin - Selected References Aronoff GA, Bennett WM, Berns JS, et al. Drug prescribing in renal failure: dosing guidelines for adults and children. 5th ed. Philadelphia: American College of Physicians; 2007. Buck AC, Cohen SL. Absorption of antibiotics during peritoneal dialysis in patients with renal failure. J Clin Pathol. 1968;21:88–92. Cabana BE, Taggart JG, Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans. Antimicrob Agents Chemother. 1973;3:478–83. Christopher TG, Blair AD, Forrey AW, Cutler RE. Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy. J Pharmacokinet Biopharm. 1976;4:427–41. Clarke JT, Libke RD, Regamey C, Kirby WMM. Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther. 1974;15:610–6. Cutler RE, Orme BM. Correlation of serum creatinine concentration and kanamycin half-life. JAMA. 1969;209:539–42. Danish M, Schultz R, Jusko WJ. Pharmacokinetics of gentamicin and kanamycin during hemodialysis. Antimicrob Agents Chemother. 1974;6:841–7. Ericsson CD, Duke JH Jr, Pickering LK. Clinical pharmacology of intravenous and intraperitoneal aminoglycoside antibiotics in the prevention of wound infections. Ann Surg. 1978;188:66–70. Greenberg PA, Sanford JP. Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis: tetracycline, chloramphenicol, kanamycin, and colistimethate. Ann Intern Med. 1967;66:465–79. Healy JK, Drum PJ, Elliott AJ. Kanamycin dosage in renal failure. Aust NZ J Med. 1973;3:474–9. Hollenberg NK, Adams DF, Oken DE, Abrams HL, Merrill JP. Acute renal failure due to nephrotoxins: renal hemodynamic and angiographic studies in man. N Engl J Med. 1970;282:1329–34. Kanamycin injection USP [package insert]. Schaumburg: APP Pharmaceuticals LLC; 2008. Kirby WM, Clarke JT, Libke RD, Regamey C. Clinical pharmacology of amikacin and kanamycin. J Infect Dis. 1976;134(Suppl):S312–5. Kunin CM. Nephrotoxicity of antibiotics. JAMA. 1967;202:204–8. Kunin CM, Finland M. Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin. J Clin Invest. 1959;38:1509–19. Mawer GE, Knowles BR, Lucas SB, Stirland RM, Tooth JA. Computer-assisted prescribing of kanamycin for patients with renal insufficiency. Lancet. 1972;1:12–5. Mingeot-Leclercq M-P, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother. 1999;43:727–37. Neu HC. Clinical use of aminoglycosides. In: Whelton A, Neu HC, editors. The aminoglycosides: microbiology, clinical use, and toxicology. New York: Marcel Dekker; 1982:611–28. Nielsen B, Sørensen AWS, Szabo L, Aagaard Pedersen E, Scharff A. Kanamycin serum half-life and renal function: age and sex. Dan Med Bu
Data Loading...
